Sept. 26, 2021, 12:17 p.m.
(ABC News) Pfizer’s CEO says “it’s a question of days, not weeks” before the company and German partner BioNTech submit data to U.S. regulators for federal authorization of a COVID-19 vaccine for children age 5 to 11
Login to grade this article.